121 related articles for article (PubMed ID: 9293965)
1. Bradykinin and endothelial-cardiac myocyte interactions in ischemic preconditioning.
Parratt JR; Vegh A; Zeitlin IJ; Ahmad M; Oldroyd K; Kaszala K; Papp JG
Am J Cardiol; 1997 Aug; 80(3A):124A-131A. PubMed ID: 9293965
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of the antiarrhythmic effects of ischaemic preconditioning by blockade of bradykinin B2 receptors.
Vegh A; Papp JG; Parratt J
Br J Pharmacol; 1994 Dec; 113(4):1167-72. PubMed ID: 7534181
[TBL] [Abstract][Full Text] [Related]
3. Preconditioning of the ischaemic myocardium; involvement of the L-arginine nitric oxide pathway.
Vegh A; Szekeres L; Parratt J
Br J Pharmacol; 1992 Nov; 107(3):648-52. PubMed ID: 1472963
[TBL] [Abstract][Full Text] [Related]
4. Role of kinins in the pathophysiology of myocardial ischemia. In vitro and in vivo studies.
Linz W; Wiemer G; Schölkens BA
Diabetes; 1996 Jan; 45 Suppl 1():S51-8. PubMed ID: 8529801
[TBL] [Abstract][Full Text] [Related]
5. Delayed protection against ventricular arrhythmias by cardiac pacing.
Parratt JR; Vegh A
Heart; 1997 Nov; 78(5):423-5. PubMed ID: 9414995
[No Abstract] [Full Text] [Related]
6. Modification by bradykinin B2 receptor blockade of protection by pacing against ischaemia-induced arrhythmias.
Kaszala K; Végh A; Papp JG; Parratt JR
Eur J Pharmacol; 1997 Jun; 328(1):51-60. PubMed ID: 9203568
[TBL] [Abstract][Full Text] [Related]
7. The potential antiarrhythmic effects of exogenous and endogenous bradykinin in the ischaemic rat heart in vivo.
Sun W; Wainwright CL
Coron Artery Dis; 1994 Jun; 5(6):541-50. PubMed ID: 7952414
[TBL] [Abstract][Full Text] [Related]
8. Bradykinin is a mediator, but unlikely a trigger, of antiarrhythmic effects of ischemic preconditioning.
Driamov SV; Bellahcene M; Butz S; Buser PT; Zaugg CE
J Cardiovasc Electrophysiol; 2007 Jan; 18(1):93-9. PubMed ID: 17229306
[TBL] [Abstract][Full Text] [Related]
9. Antiarrhythmic effect of ischemic preconditioning during low-flow ischemia. The role of bradykinin and sarcolemmal versus mitochondrial ATP-sensitive K(+) channels.
Driamov S; Bellahcene M; Ziegler A; Barbosa V; Traub D; Butz S; Buser PT; Zaugg CE
Basic Res Cardiol; 2004 Jul; 99(4):299-308. PubMed ID: 15221348
[TBL] [Abstract][Full Text] [Related]
10. Coronary endothelial dysfunction increases the severity of ischaemia-induced ventricular arrhythmias in rat isolated perfused hearts.
Hassanabad ZF; Furman BL; Parratt JR; Aughey E
Basic Res Cardiol; 1998 Aug; 93(4):241-9. PubMed ID: 9782365
[TBL] [Abstract][Full Text] [Related]
11. Repeated cardiac pacing extends the time during which canine hearts are protected against ischaemia-induced arrhythmias: role of nitric oxide.
Kis A; Végh A; Papp JG; Parratt JR
J Mol Cell Cardiol; 1999 Jun; 31(6):1229-41. PubMed ID: 10371697
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of angiotensin-converting enzyme increases the nitric oxide levels in canine ischemic myocardium.
Kitakaze M; Node K; Minamino T; Asanuma H; Ueda Y; Kosaka H; Kuzuya T; Hori M
J Mol Cell Cardiol; 1998 Nov; 30(11):2461-6. PubMed ID: 9925380
[TBL] [Abstract][Full Text] [Related]
13. Bradykinin as an endogenous myocardial protective substance with particular reference to ischemic preconditioning--a brief review of the evidence.
Parratt JR; Vegh A; Papp JG
Can J Physiol Pharmacol; 1995 Jul; 73(7):837-42. PubMed ID: 8846418
[TBL] [Abstract][Full Text] [Related]
14. Pronounced antiarrhythmic effects of ischemic preconditioning.
Parratt J; Vegh A
Cardioscience; 1994 Mar; 5(1):9-18. PubMed ID: 8204800
[TBL] [Abstract][Full Text] [Related]
15. Effects of delayed preconditioning on myocardial regional contractility during repeated episodes of low-flow ischaemia in anaesthetized dogs: possible role of nitric oxide.
Szigeti Z; Simon K; Parratt JR; Végh A
Clin Sci (Lond); 2004 Feb; 106(2):201-13. PubMed ID: 14556644
[TBL] [Abstract][Full Text] [Related]
16. Are ATP sensitive potassium channels involved in the pronounced antiarrhythmic effects of preconditioning?
Vegh A; Papp JG; Szekeres L; Parratt JR
Cardiovasc Res; 1993 Apr; 27(4):638-43. PubMed ID: 8324798
[TBL] [Abstract][Full Text] [Related]
17. Cardiac interstitial bradykinin release during ischemia is enhanced by ischemic preconditioning.
Pan HL; Chen SR; Scicli GM; Carretero OA
Am J Physiol Heart Circ Physiol; 2000 Jul; 279(1):H116-21. PubMed ID: 10899048
[TBL] [Abstract][Full Text] [Related]
18. Prevention by an inhibitor of the L-arginine-nitric oxide pathway of the antiarrhythmic effects of bradykinin in anaesthetized dogs.
Vegh A; Papp JG; Szekeres L; Parratt JR
Br J Pharmacol; 1993 Sep; 110(1):18-9. PubMed ID: 7693277
[TBL] [Abstract][Full Text] [Related]
19. Local inhibition of bradykinin degradation in ischemic hearts.
Linz W; Martorana PA; Schölkens BA
J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S99-109. PubMed ID: 1697370
[TBL] [Abstract][Full Text] [Related]
20. The effects of Z13752A, a combined ACE/NEP inhibitor, on responses to coronary artery occlusion; a primary protective role for bradykinin.
Rastegar MA; Marchini F; Morazzoni G; Vegh A; Papp JG; Parratt JR
Br J Pharmacol; 2000 Feb; 129(4):671-80. PubMed ID: 10683191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
